Thomas McGauley

Chief Financial Officer, GALECTIN THERAPEUTICS INC.

Companies

TENAX THERAPEUTICS, INC.Chief financial officer Dec 6, 2024 to May 13, 2026¹
GALECTIN THERAPEUTICS INCChief financial officer May 25, 2012 to Jun 21, 2013²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

TENAX THERAPEUTICS, INC. TENX7,000 shares³$10.6K at $1.51Feb 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 17, 2025Bought 5,000 shares at $7.23 of TENAX THERAPEUTICS, INC.⁴
Nov 17, 2025Bought 1,000 shares at $7.35 of TENAX THERAPEUTICS, INC.⁴
Nov 17, 2025Bought 2,000 shares at $7.34 of TENAX THERAPEUTICS, INC.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTENAX THERAPEUTICS, INC., Chief financial officer
2
SEC EDGARGALECTIN THERAPEUTICS INC, Chief financial officer
3
SEC EDGARTENAX THERAPEUTICS, INC. shares after the filing of Feb 3, 2026
4
SEC EDGARForm 4 filed Nov 19, 2025